title: Catheter-associated thrombosis: thromboprophylaxis for cancer patients who carry factor V Leiden?
authors.forename: G
authors.initials: G
authors.lastname: Ferretti
authors.forename: E
authors.initials: E
authors.lastname: Bria
authors.forename: A
authors.initials: A
authors.lastname: Felici
authors.forename: P
authors.initials: P
authors.lastname: Carlini
authors.forename: D
authors.initials: D
authors.lastname: Giannarelli
authors.forename: M
authors.initials: M
authors.lastname: Ciccarese
authors.forename: P
authors.initials: P
authors.lastname: Papaldo
authors.forename: A
authors.initials: A
authors.lastname: Fabi
authors.forename: A
authors.initials: A
authors.lastname: Gelibter
authors.forename: F
authors.initials: F
authors.lastname: Cognetti
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D002404:Catheterization / Q000009:adverse effects*; D015331:Cohort Studies; D005165:Factor V / Q000235:genetics*; D006801:Humans; D009154:Mutation; D009369:Neoplasms / Q000150:complications*; D012189:Retrospective Studies; D013927:Thrombosis / Q000209:etiology* / Q000517:prevention & control*
chemical_list: D000970:Antineoplastic Agents; C095381:factor V Leiden; D005165:Factor V